(Q39894219)

English

The activity of extracellular signal-regulated kinase is required during G2/M phase before metaphase-anaphase transition in synchronized leukemia cell lines

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

The activity of extracellular signal-regulated kinase is required during G2/M phase before metaphase-anaphase transition in synchronized leukemia cell lines (English)

1 reference

Europe PubMed Central

15 September 2017

1 reference

based on heuristic

inferred from title

author name string

Katarina Matkovic

1

1 reference

Europe PubMed Central

15 September 2017

Vesna Lukinovic-Skudar

2

1 reference

Europe PubMed Central

15 September 2017

Hrvoje Banfic

3

1 reference

Europe PubMed Central

15 September 2017

Dora Visnjic

4

1 reference

Europe PubMed Central

15 September 2017

publication date

17 January 2009

1 reference

Europe PubMed Central

15 September 2017

International Journal of Hematology

1 reference

Europe PubMed Central

15 September 2017

89

1 reference

Europe PubMed Central

15 September 2017

2

1 reference

Europe PubMed Central

15 September 2017

159-166

1 reference

Europe PubMed Central

15 September 2017

https://scigraph.springernature.com/pub.10.1007/s12185-008-0248-3

0 references

Nuclear phospholipase C-beta1b activation during G2/M and late G1 phase in nocodazole-synchronized HL-60 cells

1 reference

https://api.crossref.org/works/10.1007%2FS12185-008-0248-3

21 January 2018

Two waves of the nuclear phospholipase C activity in serum-stimulated HL-60 cells during G(1) phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1007%2FS12185-008-0248-3

21 January 2018

Nuclear phosphoinositide 3-kinase C2beta activation during G2/M phase of the cell cycle in HL-60 cells

1 reference

https://api.crossref.org/works/10.1007%2FS12185-008-0248-3

21 January 2018

Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-008-0248-3

21 January 2018

The MAP kinase pathway is required for entry into mitosis and cell survival.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of MAPKs by growth factors and receptor tyrosine kinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of the nuclear Akt activation and Akt inhibitors in all-trans-retinoic acid-differentiated HL-60 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of extracellular signal-regulated kinase (ERK) in G2 phase delays mitotic entry through p21CIP1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells: a role for the MAP kinase pathway in regulating mitotic exit

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERK implication in cell cycle regulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erk5 is activated and acts as a survival factor in mitosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphorylation of the cyclin b1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific inhibition of basal mitogen-activated protein kinases and phosphatidylinositol 3 kinase activities in leukemia cells: a possible therapeutic role for the kinase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p42-MAP kinase is activated in EGF-stimulated interphase but not in metaphase-arrested HeLa cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinoid X receptor alpha is highly phosphorylated in retinoic acid-resistant HL-60R cells and the combination of 9-cis retinoic acid plus MEK inhibitor induces apoptosis in the cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical experience of MEK inhibitors in cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Akt-induced promotion of cell-cycle progression at G2/M phase involves upregulation of NF-Y binding activity in PC12 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Raf-1/MEK/MAPK pathway is necessary for the G2/M transition induced by nocodazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Map kinase signaling pathways and hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a novel inhibitor of mitogen-activated protein kinase kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-008-0248-3

1 reference

Europe PubMed Central

15 September 2017

release_4cu6qza6lnaghldhztnbk3uu2q

1 reference

https://api.fatcat.wiki/v0/release/4cu6qza6lnaghldhztnbk3uu2q

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39894219&oldid=2092242104"